
Minocycline Hydrochloride is a potent second-generation tetracycline antibiotic used to treat bacterial infections and acne. Zyntex provides high-purity API for pharmaceutical use
In the field of pharmaceutical manufacturing, the stability of the active ingredient determines the ultimate clinical success of the drug. Minocycline Hydrochloride is specifically selected for its broad-spectrum antibacterial activity against both Gram-positive and Gram-negative organisms. For instance, it effectively inhibits bacterial protein synthesis by binding to the 30S ribosomal subunit. Consequently, it remains a primary choice for treating severe acne vulgaris and various respiratory tract infections. As a result, Zyntex ensures that every batch meets the rigorous standards of global pharmacopoeias (USP/EP/BP).
Moreover, the high-purity API provided by Zyntex possesses excellent solubility in water and organic solvents. This versatility allows formulators to develop diverse delivery systems with predictable bioavailability. Undoubtedly, its anti-inflammatory properties further enhance its therapeutic value in treating chronic inflammatory conditions beyond simple bacterial clearance. At the same time, our manufacturing process maintains strictly controlled impurity profiles and moisture levels. In short, our product serves as a reliable foundation for pharmaceutical companies aiming to produce high-quality generic or branded medications.
Recently, this compound has also gained attention in neuroprotective research due to its ability to cross the blood-brain barrier. Because of this, Zyntex supports advanced R&D projects exploring its potential in treating various central nervous system disorders. Ultimately, by partnering with us, you secure a supply chain that guarantees chemical integrity and regulatory compliance. Sonuç itibariyle (To conclude), our commitment to quality helps your medical formulations achieve the highest levels of safety and efficacy in the global healthcare market.
This professional-grade antibiotic API is specifically vital in the following four medical sectors:
Primary active agent in capsules and tablets for systemic infections; thus ensuring rapid bacterial inhibition.
Used in topical gels and oral forms for moderate-to-severe acne; consequently reducing inflammation and lesions.
Essential for neuroprotection and anti-inflammatory research; undoubtedly expanding its therapeutic scope.
Applied in treating specific conditions like rheumatoid arthritis or meningococcal carrier states.
| Parameter | Standard Value |
|---|---|
| Product Name | Minocycline Hydrochloride |
| Purity (Assay) | 99.0% – 101.0% (on anhydrous basis) |
| Appearance | Yellow Crystalline Powder |
| CAS Number | 13614-98-7 |
🔬 Scientific Data: For detailed pharmacokinetics, antimicrobial spectra, and safety data, visit the external source: PubChem: Minocycline Hydrochloride (External Link)